ArticleAmerican journal of hematology2023

Lovo-cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB-206 study.

Julie Kanter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.